Markets › United States › NAS › CUVL

Clinuvel Pharmaceuticals Ltd.

NAS:CUVLHealthcarenasdaq_composite

$5.19−0.95%At closeAt close · Tue 20 Oct · ≈ AED 19.06 · Market cap $262.51M · Next earnings Tue 23 Feb

USD millions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Depreciation & amortization	0.6	0.5	0.5	0.7	0.7	0.7	−10.0%
Change in working capital	(8.5)	4.3	(2.2)	(4.2)	1.4	(2.2)	−255.2%
Operating cash flow	14.4	28.9	24.8	24.3	26.6	25.0	−6.0%
Capital expenditure	(0.6)	(0.3)	(0.7)	(3.7)	(0.2)	(1.1)	−461.4%
Dividends paid	(0.9)	(0.9)	(1.3)	(1.6)	(1.6)	(1.7)	−4.7%
Free cash flow	13.7	28.6	24.1	20.6	26.4	23.9	−9.4%